Metabolic-Fit / 100
Sprout Health review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.
then $299/mo ongoing
- Confirm HSA / FSA coverage
- Public signup path reviewed
- Confirm your total cost
We may earn a referral fee
Sprout Health at a glance
- Semaglutide
- $299 per 4 weeks
- Tirzepatide
- $349 per 4 weeks
- Coverage
- 44 states (not AL, AR, CA, LA, MS, ND)
- Brand-name
- Compounded only
How we scored Sprout Health
Every factor comes from Sprout Health's own published pricing, disclosures and oversight, and the six combine into the 61/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
$299 for semaglutide and $349 for tirzepatide every four weeks are the standing rates, the same at any dose. The $149 and $199 on the homepage are first-month prices after $150 off, and a 12-month plan paid up front brings it to $99 and $149 a month. Six states are out. The Better Business Bureau rates Sprout F, with 64 complaints on file and 32 of them unanswered.
What to expect when you sign up
We walked Sprout Health's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Land on one of many quiz landers — the sitemap carries separate pages per traffic source, including /quiz-weightloss-forbes/ and /quiz-weightloss-webmd/ — each leading with a different teaser price
- 2Brand-name pens are advertised alongside them: Wegovy® at $1,579 on one homepage and $1,799 on the other, Zepbound® at $1,249 and $1,999
- 3Answer goal, sex assigned at birth, age band and state, then height and weight; no price is shown at any quiz step, only a promo-code banner
- 4You are charged before the medical review — the site states so plainly — and the detailed medical questionnaire comes after purchase
What we noticed
- The homepage's $149 and $199 are first-month prices after $150 off, though the card labels them the monthly plan price; the standing price in its own FAQ is $299 and $349
- Different landers have run different first-month promotions, so the entry price can depend on which page you arrive on
- Pricing is flat across dose escalations, stated verbatim: the monthly payment 'will never increase … EVEN IF your dosage increases in subsequent months'
- The terms publish an explicit state list — 44 states, excluding Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota — but the intake quiz accepted California without blocking
- Two partner compounding pharmacies are named (Foothills Pharmacy and Promise Pharmacy), as is the clinician network, MD Integrations; no medical director is named anywhere
- The 'Excellent 4.9' rating shown on its landers is a hardcoded image, not a live review widget; its actual Trustpilot score is 3.7 across 122 reviews
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $149 → $299 | Monthly plan$299 per 4-week supply at any dose. The $149 on the homepage is the first month after $150 off (code FIRST150), though the homepage card labels it the monthly plan price. |
| Compounded tirzepatide | $199 → $349 | Monthly plan$349 per 4-week supply at any dose. The $199 shown on the homepage and tirzepatide page is the first month after $150 off. |
| Compounded semaglutide | $99 | 12-month plan$99 a month, billed $1,188 up front for 12 months and renewing until you cancel. |
| Compounded tirzepatide | $149 | 12-month plan$149 a month, billed $1,788 up front for 12 months and renewing until you cancel. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Sprout Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
Prices move. Check today's number for your dose.See plans at Sprout Health
What we like
- Flat pricing through every dose escalation, stated explicitly — the bill does not climb as you titrate up
- Names its two partner compounding pharmacies and its clinician network, which is more disclosure than much of this market offers
- Publishes an explicit 44-state list in its terms rather than leaving coverage vague
- Offers a sublingual option for anyone who wants to avoid injections, and a 12-month plan that cuts the monthly rate
- A staffed support phone line with published weekday hours
The caveats
- Carries an FDA warning letter (MARCS-CMS 715879, issued 9 September 2025) over marketing that described GLP-1 medications as FDA-approved; FDA's index records no response and no close-out
- Rated F by the Better Business Bureau, with 64 complaints on file and 32 of them unanswered
- You are charged before the medical review; the detailed medical questionnaire comes after purchase
- Two contradictory refund policies are live at once — its main site promises staged refunds minus a $50 clinical-review fee, its landing-page domain says all prescription medications are non-refundable
- The $149/$199 homepage figures are first-month prices after $150 off; the standing price in its own FAQ is $299/$349 every four weeks
- Not available in Alabama, Arkansas, California, Louisiana, Mississippi or North Dakota — though the intake quiz accepted California without blocking
- The 'Excellent 4.9' rating on its landers is a hardcoded image; the live Trustpilot score is 3.7
- No medical director is named, no lab work is mentioned anywhere, and there is no postpartum, breastfeeding or PCOS material of any kind
Weighed the likes and the caveats? See the plans for yourself.See plans at Sprout Health
An open FDA letter, and brand pens you cannot actually buy
Sprout Health carries an FDA warning letter — MARCS-CMS 715879, issued 9 September 2025 — over marketing that described GLP-1 medications as FDA-approved. FDA's index records no response and no close-out, which means the file is open rather than resolved.
The site also advertises Wegovy and Zepbound at roughly $1,249 to $1,999. You cannot buy them. A price attached to a product a customer cannot purchase is advertising rather than pricing, and given the letter is about describing compounded medication as approved medication, the two findings point in the same direction.
The Better Business Bureau rates Sprout Health F, with 64 complaints on file and 32 of them unanswered. We keep it listed because a letter discloses rather than disqualifies — but a reader deciding tonight deserves all three of those facts before a price.
What it does well, which is not nothing
Pricing is flat through every dose escalation, stated explicitly — the bill does not climb as you titrate up, which is the trap in a large part of this market. Semaglutide is $299 a month and tirzepatide $349, and those are the standing rates rather than a teaser. The widely repeated $149 is not a price anyone keeps paying.
It names its two partner compounding pharmacies and its clinician network, and it publishes an explicit 44-state list in its terms rather than leaving coverage vague — both more disclosure than much of this market offers. A sublingual option is available for anyone avoiding injections, and three- and six-month tiers cut the monthly figure substantially.
- Semaglutide: $299/mo flat at all doses · $205 on 3 months · $169 on 6
- Tirzepatide: $349/mo flat at all doses · $250 on 3 months · $229 on 6
- Disclosed: two named pharmacies, the clinician network, and an explicit state list
- Not available in: AL, AR, CA, LA, MS, ND
- Advertised but not purchasable: Wegovy and Zepbound
The multi-month tiers are where the price actually lands
The gap between the monthly rate and the six-month tier is large — $299 down to $169 on semaglutide, $349 down to $229 on tirzepatide. That is a bigger discount than most of our list offers for committing, and it is the shape of the offer: the monthly price is not really the product, the multi-month plan is.
Which puts more weight, not less, on the record above. Committing six months to a company with an open FDA letter and 32 unanswered complaints is a different decision from paying for one month and seeing how it goes, and the pricing is designed to push you toward the first. If you do go ahead, the month-to-month rate is the cautious way in even though it costs more.
Who this suits
Someone who wants flat-through-titration pricing on a compounded program, has read the letter and the BBB record and judged them acceptable, and is buying the compounded product rather than being drawn in by the brand pens on the page. If the brand names are what brought you, they are not available here — our cost and insurance guide covers the routes that do sell them.
The bottom line for mothers
Best for: Cost-focused mothers outside its six excluded states who want a price that does not climb as they titrate, and who have read the regulatory record below and are comfortable with it.
Alternatives to Sprout Health
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Enhance MD81
Metabolic-Fit / 100
A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.
- Visit Willow66
Metabolic-Fit / 100
Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.
Providers like Sprout Health
Keep comparing Sprout Health
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Sprout Health, answered
- Is Sprout Health's $149 price real?
- It is a first-month rate, not the ongoing price. The $149 semaglutide and $199 tirzepatide on the homepage are the first month after $150 off. The standing price is $299 for compounded semaglutide and $349 for compounded tirzepatide every four weeks. The only lower ongoing rate is the 12-month plan, $99 and $149 a month, billed $1,188 or $1,788 up front and renewing until you cancel. Budget on $299, not $149.
- Can I actually get Wegovy or Zepbound from Sprout Health?
- No, and this is the most important thing on the page. If an FDA-approved pen is what you want — and for a mother weighing timing around pregnancy, the on-label product with its own labeling is a reasonable thing to want — you will not get one here.
- Does Sprout Health have a regulatory record I should know about?
- Yes, and we would rather you hear it from us. FDA issued Sprout a warning letter on 9 September 2025 (MARCS-CMS 715879) over marketing that described GLP-1 medications as FDA-approved; FDA's index shows no response and no close-out. It also holds a Better Business Bureau rating of F, with 64 complaints on file and 32 of them unanswered. In fairness, the FDA letter concerns how the product was described in marketing rather than a finding about the medication itself — but an unanswered complaint pattern is a reasonable thing to weigh, and both are why it sits where it does in our ranking.
- Which states does Sprout Health serve?
- 44 of them. Its terms publish the list explicitly, which is more than most of this market does. The exclusions are Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota, and the District of Columbia is not included. Worth checking first if you live in one of those — a published list is only useful if you read it before paying.
Have a question we didn't answer? Sprout Health's team can.See plans at Sprout Health
Pricing, states and verification reflect Sprout Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.